CMT-DST

DST | 2020

What Is CMT-DST?

CMT-DST is a type of CMT caused by autosomal recessive mutations in the DST gene. This gene provides instructions for making dystonin, a cytoskeletal protein that helps maintain the structural integrity of peripheral nerve cells. Mutations in the DST gene disrupt this function, leading to impaired nerve signal transmission.

CMT-DST is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in CMT-DST is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

CMT-DST symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMT-DST shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMT-DST

Classification
Unclassified Subtypes

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
DST

Gene Full Name
dystonin

Chromosome
6p12.1

Zygosity of Responsible Variant
Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
Medium

Prediction:
Reported families and the dystonia musculorum mouse point to biallelic loss of function in CMT-DST: compound-heterozygous and null DST variants remove the neuronal isoform of dystonin, the plakin-family linker that ties neurofilaments and microtubules to the actin cytoskeleton in sensory neurons, while sparing the epithelial isoform (Motley et al. 2020). Heterozygous carriers are unaffected, and the spontaneous null mouse degenerates its sensory neurons.

Rationale:
Isoform-specific truncation is the discriminating detail: variants confined to the neuronal transcript leave epidermal dystonin intact, which is why these patients have sensory loss without skin fragility. Confidence is medium because the human series is small and DST is a large, variant-tolerant gene in which assigning pathogenicity to a given allele pair is rarely straightforward.

ClinVar Pathogenic Variants

View DST ClinVar Variants

DST OMIM Entry

DST OMIM

More Info

CMT-DST Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Isoform-Specific Loss of Dystonin Causes Hereditary Motor and Sensory Neuropathy

Authors

Motley, W. W., Züchner, S., & Scherer, S. S.

Publication Date
July 31, 2020

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.